ask="0.9400"
ask_size="7000"
average_daily_volume="634992"
bid="0.8221"
bid_size="4000"
book_value="0.6070"
change="+0.0062"
change_from_200_day_moving_average="-0.5363"
change_from_50_day_moving_average="0.0668"
change_from_52_week_high="-3.5038"
change_From_52_week_low="0.1959"
change_in_percent="+0.7561%"
close="0.8262"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6470"
ebitda="-42.12M"
eps_estimate_current_year="-1.5500"
eps_estimate_next_quarter="-0.3100"
eps_estimate_next_year="-1.1800"
ex_dividend_date="N/A"
float_shares="15676000"
high="0.8816"
high_52_weeks="4.3300"
last_trade_date="1/9/2017"
last_trade_price="0.8262"
last_trade_size="800"
last_trade_time="4:00pm"
low="0.8200"
low_52_weeks="0.6303"
market_capitalization="22.67M"
moving_average_200_day="1.3625"
moving_average_50_day="0.7594"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="4.5000"
open="0.8459"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-39.3619%"
percent_change_from_50_day_moving_average="+8.7973%"
percent_change_from_52_week_high="-80.9192%"
percent_change_from_52_week_low="+31.0804%"
previous_close="0.8200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3509"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="3.3100"
stock_exchange="NGM"
symbol="CERU"
volume="370624"
weeks_range_52="0.6303 - 4.3300"
